Kelly Blackburn's most recent trade in CervoMed Inc was a trade of 27,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc | Kelly Blackburn | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 27,000 | 27,000 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Kelly Blackburn | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) |